| Sensitivity | Specificity | PPV | NPV | P value |
---|---|---|---|---|---|
Anti-CCP present | 90% | 32% | 74% | 60% | 0.05 |
RF present | 81% | 47% | 77% | 53% | 0.03 |
CRP > 18 | 66% | 63% | 79% | 46% | 0.05 |
ESR1 > 32 | 98% | 68% | 87% | 93% | 0.0001 |
ANA | 21% | 74% | 73% | 37% | NS |
AKA | 56% | 58% | 74% | 38% | NS |
Age > 50 | 32% | 90% | 86% | 38% | NS |
Duration > 6m | 98% | 11% | 70% | 67% | NS |
Risk factor | 7% | 90% | 60% | 31% | NS |
HLA-DRB1*01 | 53% | 74% | 81% | 42% | 0.05 |
HLA-DRB1*04 | 44% | 84% | 86% | 54% | 0.04 |